Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Glaukos’ Epi-on Keratoconus Therapy Meets Primary Endpoint in Phase III Trial
Glaukos announced Feb. 25 that its epi-on corneal cross-linking therapy for the treatment of keratoconus met its primary endpoint in a pivotal Phase III trial, demonstrating a statistically signifi...
US FDA Accepts NDA for Oyster Point’s Dry Eye Nasal Spray
Oyster Point Pharma announced March 2 that the US FDA had accepted its new drug application (NDA) for OC-01 (varenicline) nasal spray for the treatment of signs and symptoms of dry eye disease. The...
2020 Earnings Roundup: Glaukos, Aerie, and Two Others
Glaukos reported Feb. 25 that its net sales for full year 2020 totaled $225 million, a decrease of 5 percent from $237.0 million in 2019. Q4-2020 net sales were $73.2 million, an 11 percent increas...
Iridex, Topcon Join Forces in Glaucoma, Retinal Disease Treatment
Iridex and Topcon announced March 2 that the companies will collaborate worldwide on glaucoma and retinal disease treatments. Iridex will get in $19.5 million in cash from Topcon in the deal. Topco...
US FDA Accepts Eyenovia NDA for Fixed Combination Mydriatic Agent
Eyenovia, of New York, announced March 2 that the US FDA had accepted the company’s new drug application (NDA) for MydCombi, a fixed combination mydriatic (pupil dilation) agent. MydCombi (phenylep...
Congress-Mandated Study Tackles Drug Waste in Single-Dose Vials
A group of top US scientists studying drug waste in single-dose vials has recommended eliminating the 6 percent add-on payment made to physicians for Medicare Part B drugs and instead reimbursing p...
Ophthalmic Innovator George Marcellino, PhD, Dies
Longtime ophthalmic innovator George Marcellino, PhD, died unexpectedly Feb. 10, 2021, Iridex reported on its website. Dr. Marcellino had been serving as Iridex’ vice president of clinical affairs ...
$20 Million Gift to Fund Vision Care Research at University of Pittsburgh Medical Center
The University of Pittsburgh Medical Center (UPMC) announced Feb. 25 that a $20 million gift from the Henry L. Hillman Foundation will fund vision care research and development. The gift was made t...
NEI, Southeast Asian Ophthalmic Groups Announce Meeting on Scientific Collaboration
The National Eye Institute and Association of Southeast Asian Nations Ophthalmology Society, along with experts from several renowned institutions, will hold a free virtual symposium in mid-March t...
Optimo’s Collaboration with Ansys Yields Surgical Planning Simulator for Treating Astigmatism
Simulation innovators Optimo Medical AG and Ansys announced Feb. 23 that they have collaborated on a next-generation version of Optimo’s Optimeyes patient-specific surgical planning software for fa...
Boston Scientific Acquires Lumenis Urology, ENT Portfolio for $1.07 Billion
Boston Scientific of Marlborough, Massachusetts, announced March 3 that it was acquiring theLumenis surgical business for urology and otolaryngology (ears, nose, and throat, or ENT) from Baring Pri...
DTx Pharma Raises $100 Million in Series B Round to Advance its RNA Therapeutics Pipeline
DTx Pharma, of San Diego, California, announced March 1 that it had completed a $100 million Series B financing. Arthur T. Suckow, PhD, chief executive officer of DTx Pharma, said the money would a...
Past News Stories
Oxular Raises $37 Million to Advance DME Candidate, Others
Oxular Limited announced March 1 that it had completed a $37 million financing led by European life sciences venture capital firm Forbion. The Oxford, England, company said the money would fund Pha...
Gene Therapy Developer SalioGen Closes $20 Million Series A Round
SalioGen Therapeutics of Burlington, Massachusetts, announced March 1 that it had closed a $20 million Series A financing to support development of nonviral gene therapies. Proceeds will be used fo...
Market Scope Tracking Status of 2021 Ophthalmic Meetings
Market Scope is tracking the status of 2021 ophthalmic meetings as the world tries to recover from COVID-19. Here is the latest information: Organization Status Date Location More Information Glauc...
Allergan Submits New Drug Application to US FDA for Presbyopia Drop
Allergan, an AbbVie company, announced Feb. 25 that it had submitted a new drug application (NDA) to the US FDA for AGN-190584 (pilocarpine 1.25%) ophthalmic solution for symptoms of presbyopia. Th...
AcuFocus Submits US Premarket Approval Application for IC-8 Small Aperture IOL
AcuFocus announced Feb. 23 that it had submitted a premarket approval (PMA) application to the US FDA for its IC-8 small aperture IOL. The IC-8 is an aspheric monofocal lens that features an embedd...
2020 Earnings Roundup: Alcon, Bausch, Horizon, and Four More
Alcon reported Feb. 23 that full-year 2020 revenue totaled $6.8 billion, a decrease of 8 percent on a reported and constant currency basis, from $7.4 billion in 2019. The company said a substantial...
Oculogenex Gene Therapy Startup Wins Winning Pitch Challenge—Retina
Ophthalmologist Hema Ramkumar, MD, won the 2021 Winning Pitch Challenge—Retina, a virtual competition held Feb. 6. Ramkumar, a surgeon at Retina Consultants of Orange County, is the founder of Ocul...
Oertli Begins Construction of New Production and Logistics Factory
Swiss ophthalmic surgical instrument maker Oertli announced Feb. 17 that it had started construction on a new factory at its location in Berneck. The three-story production and logistics building w...
I-MED Pharma Shifts Surgical Portfolio to Keir to Focus on Dry Eye
I-MED Pharma, of Montreal, Canada, announced Feb. 2 that Keir Surgical had taken ownership of its ophthalmic surgical portfolio. No financial details were given. I-MED said it would reinvest the pr...
UK’s Medicom Buys Generic Bimatoprost from Famar of Spain
Medicom Healthcare Limited, of the UK, announced Feb. 10 that it had acquired the product dossier of bimatoprost 0.3 mg/mL, 3ml, preservative-free eye drop solution from Spain’s Famar Health Care S...
Ocugen Gene Therapy Candidate for RP, LCA Gains Orphan Status in EU
Ocugen announced Feb. 23that the European Commission had granted orphan medicinal product designation for its OCU400 gene therapy candidate for retinitis pigmentosa (RP) and Leber congenital amauro...
Australia’s PYC Therapeutics Aims to Transition to US-Based Clinical-Stage Company
Australian company PYC Therapeutics, in a press release Feb. 22, cited progress in its transition to a US-based clinical-stage company, highlighting three RNA therapeutics in preclinical developmen...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.